PharmiWeb.com - Global Pharma News & Resources
17-Apr-2019

Preterm Birth and PROM Testing Market to Cross USD 1.31 Billion by 2026

The Global Preterm Birth and PROM Testing Market size was valued at 1.11 billion in 2017. The market is estimated to grow at a CAGR of 1.74% over the forecast period.

Premature rupture of membranes (PROM) causes roughly 4.5 Million preterm births every year, around the world. Comprehensively, premature birth is among the most incessant reasons for death among neonates within the first month of their life. The endorsement of preterm birth and PROM testing demonstrative units has presented an exceptionally effectual yet cost-effective choice for testing premature rupture of membranes in symptomatic patients. These tests are progressively supplanting conventional standard-of-care tests (Fern and Nitrazine) propelled by their usability and high affectability.

Rising occurrence of preterm births, expanding land reach by market players, extreme interest for the viable conclusion of preterm births, and propelled sedate conveyance gadgets are expected to drive the market. The increment in the number of preterm births, high frequency of preterm births, ascend in the quantity of claim to fame facilities, and simple location of preterm birth through PROM tests are projected to enlarge the fragment. The preterm birth tests segment capture the highest revenue share of the worldwide preterm birth and PROM testing market. However, the accessibility of different tests in the market is estimated to hamper the market growth over the forecast period.

The global preterm birth and PROM testing market is divided into test type, end-user, and region. On the basis of test type segment, the worldwide preterm birth and PROM testing market is divided into preterm birth tests and PROM tests. Whereas, preterm birth tests segment includes pelvic exam, ultrasound, uterine monitoring, and biomarkers, and prom test includes nitrazine test, ferning test, pooling, ultrasound, fetal fibronectin test, biomarker tests, and others. On the basis of application, the worldwide preterm birth and PROM testing market is segmented into hospitals, diagnostic laboratories, and others. Based on the region, the worldwide preterm birth and PROM testing market is divided into North America, Latin America, Europe, Middle East and Africa, and the Asia Pacific.

Free Download Sample Report Pages for Better understanding at https://www.acumenresearchandconsulting.com/request-sample/1263

Preterm birth is a birth that happens before 37weeks of pregnancy is finished. Premature rupture of membranes (PROM) is a typical pregnancy complexity and is one of the main sources of preterm births. Preterm birth and premature rupture of membranes (PROM) testing are comprehensively sectioned into preterm birth testing and premature rupture of membrane (PROM) testing. The preterm birth testing incorporates fetal fibronectin (fFN) test, Kleihauer blood test, total blood tally test, and c-responsive protein test; while PROM testing incorporates nitrazine tests, ferning test, biomarker tests, such as, Placental Alpha Microglobulin-1 (PAMG-1) Test, IGFBP-1 (Insulin-Like Growth Factor Binding Protein-1) Test, and Alpha-Fetoprotein (AFP) Test.

As per WHO, preterm birth is a worldwide medical problem with about 1.5 million preterm births every year. Moreover, about 60% of preterm births happen in South Asia and sub-Saharan African nations. In this manner, these untapped developing markets are projected to offer potential development opportunities to players working in the market during the estimated time frame. Nonetheless, low dependability of test outcomes is probably posing a challenge, hindering the market growth.

The high presence of major players, incremented demand for preterm birth testing, and an increase in preterm birth rates are some factors boosting the market growth in North America. Innovative and technical advancement, a rise in the number of endorsements for preterm and PROM tests from the European Commission, and rising demand after for preterm birth symptomatic tests fueling the preterm birth and PROM testing market in Europe. Concentrate on early medical issues in females, a rise in government activities related to maternal wellbeing, and increment in the number of preterm births are some of the factors that are driving the market in the Asia Pacific. The growing market in Latin America owing to a quick selection of new advancements, increasing use of point-of-care testing gadgets and devices, and the increase in the volume of players offering the target product in the market. Furthermore, the rise in awareness related to item offerings for preterm birth and PROM testing is expected to expand the market in Latin America during the estimated time frame.

Major companies contributing the global preterm birth and PROM testing market are Qiagen, Hologic, Cooper Surgical, Abbott Laboratories, Medixbiochemica, Sera Prognostics, Biosynex, and IQ Products.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

CHAPTER 4. PRETERM BIRTH AND PROM TESTING MARKET BY TEST TYPE

CHAPTER 5. NORTH AMERICA PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

CHAPTER 6. EUROPE PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

CHAPTER 7. ASIA-PACIFIC PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

CHAPTER 8. LATIN AMERICA PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

CHAPTER 9. MIDDLE EAST PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

CHAPTER 10. AFRICA PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

CHAPTER 11. COMPANY PROFILE

CHAPTER 12. RESEARCH APPROACH

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report at https://www.acumenresearchandconsulting.com/buy-now/0/1263

Editor Details

Last Updated: 17-Apr-2019